Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Xitlally Popa"'
Autor:
Xitlally Popa, Beatriz García, Karla P. Fuentes, Vivian Huerta, Karen Alvarez, Carmen E. Viada, Elia Neninger, Pedro C. Rodríguez, Zuyen González, Amnely González, Tania Crombet, Zaima Mazorra
Publikováno v:
OncoImmunology, Vol 9, Iss 1 (2020)
We previously reported that CIMAvax-EGF vaccine is safe, immunogenic and efficacious to treat advanced non-small-cell lung cancer (NSCLC) patients. A phase III trial was designed using an optimized immunization schedule. It included higher antigen do
Externí odkaz:
https://doaj.org/article/e59a8c57e455495bbcf63ebd16c0a490
Autor:
Iraida Caballero, Lazaro E. Aira, Anabel Lavastida, Xitlally Popa, Javier Rivero, Joaquín González, Mónica Mesa, Narjara González, Kelly Coba, Patricia Lorenzo-Luaces, Barbara Wilkinson, Yuliannis Santiesteban, Yanela Santiesteban, Mayelin Troche, Eduardo Suarez, Tania Crombet, Belinda Sánchez, Angel Casacó, Amparo Macías, Zaima Mazorra
Publikováno v:
Frontiers in Pharmacology, Vol 8 (2017)
Metastatic castration-resistant prostate cancer (CRPC) remains incurable due to the lack of effective therapies. Activation of the human epidermal growth factor receptor 1 (HER1) in prostate cancer contributes to metastatic progression as well as to
Externí odkaz:
https://doaj.org/article/6a43783a38494fe991499aa5a8d5c895
Autor:
Xitlally, Popa-Navarro1 (AUTHOR), Alejandro, Avilés-Salas2 (AUTHOR), Norma, Hernández-Pedro1 (AUTHOR) nhernandezp@incan.edu.mx, Mario, Orozco-Morales1 (AUTHOR), Enrique, Caballé-Pérez1,3 (AUTHOR), Cesar, Castillo-Ruiz1 (AUTHOR), José, Lucio-Lozada1 (AUTHOR), Pedro, Barrios-Bernal1 (AUTHOR), Juan-Manuel, Hernandez-Martinez4 (AUTHOR), Oscar, Arrieta1,3 (AUTHOR) ogar@unam.mx
Publikováno v:
Journal of Translational Medicine. 9/12/2024, Vol. 22 Issue 1, p1-12. 12p.
Autor:
Roberto Sánchez-Reyes, Luis Cabrera-Miranda, Héctor Aquiles Maldonado-Martínez, Suraj Samtani-Bassarmal, Oscar Arrieta, Graciela Cruz-Rico, Luis Lara-Mejía, Xitlally Popa-Navarro, Rodrigo Catalán, Dennis López-Sánchez, Alejandro Avilés-Salas
Publikováno v:
Pathology and Oncology Research
Background: Programmed cell death-ligand 1 (PD-L1) protein expression is one of the most extensively studied biomarkers in patients with non-small cell lung cancer (NSCLC). However, there is scarce information regarding its association with distinct
Autor:
Zuyen Gonzalez, Carmen Viada, Zaima Mazorra, Tania Crombet, Vivian Huerta, Karen Alvarez, Karla P. Fuentes, Pedro C. Rodriguez, Beatriz García, Elia Neninger, Amnely González, Xitlally Popa
Publikováno v:
Oncoimmunology
article-version (VoR) Version of Record
OncoImmunology, Vol 9, Iss 1 (2020)
article-version (VoR) Version of Record
OncoImmunology, Vol 9, Iss 1 (2020)
We previously reported that CIMAvax-EGF vaccine is safe, immunogenic and efficacious to treat advanced non-small-cell lung cancer (NSCLC) patients. A phase III trial was designed using an optimized immunization schedule. It included higher antigen do
Autor:
Elia Neninger, Beatriz García, Karla P. Fuentes, Zaima Mazorra, Danay Saavedra, Xitlally Popa, Patricia Lorenzo-Luaces, Tania Crombet, Agustin Lage, Amnely González
Publikováno v:
Cancer Immunology, Immunotherapy. 65:37-45
There are well-known alterations occurring within the immune system with aging. Collectively, these changes are known as immunosenescence. The incidence of malignancies also increases with age. The aim of this study was to determine the presence of i
Autor:
Zuyen Gonzalez, L. Martínez, V. Huerta, Zaima Mazorra, M. Hernandez, Amnely González, Carmen Viada, Danay Saavedra, Beatriz García, Tania Crombet, K. Alvarez, E. Ibañez, Xitlally Popa, Elia Neninger, César A. Rodríguez, K. Fuentes
Publikováno v:
European Journal of Cancer. 110:S27
Autor:
Javier Rivero, Amparo Macías, Bárbara Wilkinson, Mónica Mesa, Tania Crombet, Belinda Sánchez, Xitlally Popa, Narjara González, Joaquín González, Lazaro E. Aira, Zaima Mazorra, Eduardo Suarez, Patricia Lorenzo-Luaces, Yanela Santiesteban, Angel Casacó, Mayelin Troche, Iraida Caballero, Kelly Coba, Yuliannis Santiesteban, Anabel Lavastida
Publikováno v:
Frontiers in Pharmacology, Vol 8 (2017)
Frontiers in Pharmacology
Frontiers in Pharmacology
Metastatic castration-resistant prostate cancer (CRPC) remains incurable due to the lack of effective therapies. Activation of the human epidermal growth factor receptor 1 (HER1) in prostate cancer contributes to metastatic progression as well as to
Autor:
Tania Crombet, Beatriz García, Zaima Mazorra, V. Huerta, Amnely González, Elia Neninger, Carmen Viada, Xitlally Popa, Zuyen Gonzalez, Pedro C. Rodriguez
Publikováno v:
ESMO Open. 3:A420
Introduction In previous clinical trials were reported that an EGF-based vaccine administration was immunogenic in advanced non-small cell lung cancer (NSCLC) patients and the elicited immune response was associated with patient´s survival. However,
Autor:
Zaima Mazorra, Amparo Macías, Anet Zayas, Ivis Mendoza, Ramón Ortiz, Xitlally Popa, Elena García, Eduardo Santiesteban, Roberto Gómez, Tania Crombet
Publikováno v:
Journal of Thoracic Oncology. 11:S236-S237